Psychopharmacology (2017) 234:2563–2570 DOI 10.1007/s00213-017-4646-1 ORIGINAL INVESTIGATION Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment 1 1 2 Maria Juncal-Ruiz & Mariluz Ramirez-Bonilla & Jorge Gomez-Arnau & 1 1,3 1 Victor Ortiz-Garcia de la Foz & Paula Suarez-Pinilla & Obdulia Martinez-Garcia & 4 5 1,3 Karl David Neergaard & Rafael Tabares-Seisdedos & Benedicto Crespo-Facorro Received: 15 February 2017 /Accepted: 11 May 2017 /Published online: 31 May 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract predictors of acute akathisia. Considering these results, a pre- Introduction Acute akathisia is a neuropsychiatric syndrome dictive model based of a subsample of 132 patients was con- with a negative effect on illness outcome. Its incidence in structed with akathisia as the dependent variable. patients treated with antipsychotics has shown to be highly Results The overall incidence of akathisia was 19.5%. No variable across studies. differences in demographic, biochemical, substance use, and Objectives Our goals were to investigate prevalence, risk fac- clinical variables were found. Significant incidence differ- tors for the development of acute akathisia, and differences in ences between antipsychotics were observed (Χ = 68.21, incidence between antipsychotics in a sample of
Psychopharmacology – Springer Journals
Published: May 31, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera